SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: Wharf Rat who wrote (23852)7/7/2017 5:11:20 PM
From: Steve Lokness  Respond to of 356495
 
I don't need no stinking science advisor!


Lack of treatment alternativesA lack of alternatives to the currently recommended treatment for gonorrhea makes the issue more pressing. The three antibiotic candidates currently in the pipeline—solithromycin, zoliflodacin, and gepotidacin—are in various stages of clinical development, but none are guaranteed to make it to market, Manica Balasegaram, MRCP, MSc, director of the Global Antibiotic Research and Development Partnership (GARDP), told reporters.

"The situation is, actually, fairly grim," he said.

cidrap.umn.edu



To: Wharf Rat who wrote (23852)7/7/2017 6:00:17 PM
From: i-node  Respond to of 356495
 
You are totally off course here.



To: Wharf Rat who wrote (23852)7/7/2017 6:16:55 PM
From: i-node  Read Replies (1) | Respond to of 356495
 
The point is that Feynman pointed out the flaws in so-called climate science before the current crop of bloodsuckers were even doing it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News